Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8TH85

Entry ID Method Resolution Chain Position Source
AF-Q8TH85-F1 Predicted AlphaFoldDB

No variants for Q8TH85

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q8TH85

No associated diseases with Q8TH85

3 regional properties for Q8TH85

Type Name Position InterPro Accession
domain RNA 3'-terminal phosphate cyclase, insert domain 208 - 291 IPR013791
conserved_site RNA 3'-terminal phosphate cyclase-like, conserved site 154 - 164 IPR020719
domain RNA 3'-terminal phosphate cyclase domain 8 - 343 IPR023797

Functions

Description
EC Number 6.5.1.4 Forming phosphoric ester bonds
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
RNA-3'-phosphate cyclase activity Catalysis of the reaction: ATP + RNA 3'-terminal-phosphate = AMP + diphosphate + RNA terminal-2',3'-cyclic-phosphate.

1 GO annotations of biological process

Name Definition
RNA processing Any process involved in the conversion of one or more primary RNA transcripts into one or more mature RNA molecules.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MIEIDGSYGE GGGQVVRTAV ALSAVTGKDV KVTNIRKNRP NPGLKQQHLK ALETAARICE
70 80 90 100 110 120
ARVSGLFPGS SELFFSPVEI KGGKYEVDIG TAGSITLLLQ SLMPALPFAK EKVKLTIKGG
130 140 150 160 170 180
TDVAWSPTID YLQHVTLRAL EQLGYAGIVT LKKRGYYPRG GGEVSAVFEP CKLRSFHFRR
190 200 210 220 230 240
VKENRRTGEA RREEETRNEG RNQNQRIEIQ GISHASNLPA HVPARQAEAA ESLLLEAGYG
250 260 270 280 290 300
SRTKIQSFEL LSTGSGITLW SGYCGGSALG KKGLPAEKVG RRAAEEIILE LSSKAPVDVH
310 320 330 340 350
LADQLIPYMA LAGNSSYTVR ELTLHAATNI WVTEQFLDVK FRIEEKEGLF EVSVD